Sleep Disturbances in Dermatology Patients- a Survey
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 624
- Locations
- 1
- Primary Endpoint
- Regensburg Insomnia Scale (RIS)
Study Overview
Brief Summary
This study is to investigate sleep disorders in patients with dermatologic diseases by taking into consideration dermatologic (itch, pain) and non- dermatologic (medication, depression) factors.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Cross Sectional
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Outpatients of the dermatologic university clinic
Exclusion Criteria
- •Insufficient knowledge of German language
- •Illiteracy
Outcomes
Primary Outcomes
Regensburg Insomnia Scale (RIS)
Time Frame: single time point assessment at baseline
Self-rating scale: Five items cover quantitative and qualitative sleep parameters: Sleep latency (1), sleep duration (2), sleep continuity (3), early awakening (4) and sleep depth (5). Four items cover the psychological aspects of psychophysiological insomnia (PI), such as the experience of sleepless nights (6), focussing on sleep (7), fear of insomnia (8), and daytime fitness (9), one item covers sleep medication (10). A 5-step Likert scale was provided for response.The total score ranges from 0 to 40 points (score from 0-12 points considered as normal and a higher score as indicative of PI symptoms).
Secondary Outcomes
No secondary outcomes reported